Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -17.73x is 75% below its 2-year average of -10.15x, around the middle of its 2-year range (-28.64x–-2.90x).
80.92% below its 12-month average of -9.80x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2026 (2026-06-30): -4.70x.
INTEREST COVERAGE RATIO
-17.73x
INTEREST COVERAGE RATIO AVG TTM
-9.80x
INTEREST COVERAGE RATIO AVG 3Y
N/A
INTEREST COVERAGE RATIO AVG 5Y
N/A
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-80.92%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-5.64x
median of 468 covered companies
CURRENT VS SECTOR MEDIAN
-214.08%
vs the sector median at left
DataMEDS AI, Inc.
Market Cap
$8.33M
Interest Coverage Ratio
-17.73x
TTM Avg
-9.80x
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$8.42M
Interest Coverage Ratio
-17.26x
TTM Avg
23.36x
3Y Avg
23.36x
5Y Avg
23.36x
Market Cap
$8.13M
Interest Coverage Ratio
-11.17x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$8.05M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$7.96M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$8.01M
Interest Coverage Ratio
-97.81x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$7.70M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$9.16M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$9.22M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| DataMEDS AI, Inc. (MEDS) | $8.33M | -17.73x | -9.80x | N/A | N/A |
| Healthcare Triangle, Inc. (HCTI)vs › | $8.42M | -17.26x | 23.36x | 23.36x | 23.36x |
| HeartSciences Inc. (HSCS)vs › | $8.13M | -11.17x | N/A | N/A | N/A |
| Aprea Therapeutics, Inc. (APRE)vs › | $8.05M | N/A | N/A | N/A | N/A |
| ENDRA Life Sciences Inc. (NDRA)vs › | $7.96M | N/A | N/A | N/A | N/A |
| GT Biopharma, Inc. (GTBP)vs › | $8.01M | -97.81x | N/A | N/A | N/A |
| Quince Therapeutics, Inc. (QNCX)vs › | $7.70M | N/A | N/A | N/A | N/A |
| Jasper Therapeutics, Inc. (JSPR)vs › | $9.16M | N/A | N/A | N/A | N/A |
| Advanced Biomed Inc. Common Stock (ADVB)vs › | $9.22M | N/A | N/A | N/A | N/A |
| CNS Pharmaceuticals, Inc. (CNSP)vs › | $7.34M | -1049.68x | N/A | N/A | N/A |
Interest Coverage
-17.7x
Debt/Equity
N/A
Current Ratio
0.14
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | -4.70x |
| 2026-03-31 | -2.90x |
| 2025-12-31 | -14.61x |
| 2025-09-30 | -22.13x |
| 2025-06-30 | -4.65x |
| 2025-03-31 | -28.64x |
| 2024-12-31 | -5.44x |
| 2024-09-30 | -12.68x |
| 2024-06-30 | -4.41x |
| 2024-03-31 | -4.97x |
| 2023-12-31 | -6.54x |
